Table 4
Standard Protocol Items: Recommendations for Interventional Trials schedule of enrolment, interventions and assessments.
| Study period | ||||
| Enrolment | Randomisation | Follow-up | Close-out | |
| Timepoint | −1 | 0 | 3 months ±4 weeks | 9 months ±4 weeks |
| Enrolment | ||||
| Initial contact and study information | X | |||
| Eligibility screen | X | |||
| Informed consent | X | |||
| Allocation | X | |||
| Interventions | ||||
| Group E-Rehab |  | |||
| ‘My Knee UK’ Group |  | |||
| Control group (duration of treatment will be variable) |  | |||
| Assessments | ||||
| Clinical information | ||||
| Age, gender, ethnicity | X | |||
| Previous joint surgery | X | |||
| Employment and physical activity | X | |||
| Height and weight | X | |||
| History of current knee pain | X | |||
| General health and medication use | X | X | X | |
| Patient-reported outcomes | ||||
| Joint pain manikin | X | X | X | |
| Knee pain frequency (5-point scale) | X | X | X | |
| Confidence and motivation to do exercises (11-point NRS) | X | X | X | |
| Global change (7-point Likert scale) | X | X | ||
| WOMAC (Pain, function and stiffness) | X | X | X | |
| ASES | X | X | X | |
| HADS | X | X | X | |
| Generic health status (EQ-5D-5L) | X | X | X | |
| Health-related quality of life (SF-12) | X | X | X | |
| Resource use | X | X | ||
ASES, Arthritis Self-Efficacy Scale; EQ-5D-5L, European Quality of Life-Five Dimension-Five Level Scale; HADS, Hospital Anxiety and Depression Scale; NRS, numeric rating scale; SF-12, 12-Item Short Form Survey; WOMAC, The Western Ontario and McMaster Universities Osteoarthritis Index.